|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 491/048 | (2006.01) |
| C07D 491/04 | (2006.01) |
| (11) | Number of the document | 3157928 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15733597.7 |
| Date of filing the European patent application | 2015-06-18 | |
| (97) | Date of publication of the European application | 2017-04-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-13 |
| (46) | Date of publication of the claims translation | 2019-05-27 |
| (86) | Number | PCT/US2015/036347 |
| Date | 2015-06-18 |
| (87) | Number | WO 2015/195862 |
| Date | 2015-12-23 |
| (30) | Number | Date | Country code |
| 201462014782 P | 2014-06-20 | US |
| (72) |
HALL, Michael L., US
|
| (73) |
Constellation Pharmaceuticals, Inc.,
215 First Street, Suite 200, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 2-((4S)-6-(4-chlorfenil)-1-metil-4H-benzo[c]Iizoksazolo[4,5-e]azepin-4-il)acetamido kristalinės formos |
| CRYSTALLINE FORMS OF 2-((4S)-6-(4-CHLOROPHENYL)-1-METHYL-4H-BENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-YL)ACETAMIDE |
| Payment date | Validity (years) | Amount | |
| 2025-05-19 | 11 | 289.00 EUR |
| 2026-06-18 |